000 | 02021 a2200613 4500 | ||
---|---|---|---|
005 | 20250517160222.0 | ||
264 | 0 | _c20171012 | |
008 | 201710s 0 0 eng d | ||
022 | _a1523-1747 | ||
024 | 7 |
_a10.1016/j.jid.2017.05.004 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSmith, Susan H | |
245 | 0 | 0 |
_aTapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans. _h[electronic resource] |
260 |
_bThe Journal of investigative dermatology _c10 2017 |
||
300 |
_a2110-2119 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Topical |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBasic Helix-Loop-Helix Transcription Factors _xagonists |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 |
_aDermatitis, Atopic _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammation _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
650 | 0 | 4 |
_aReceptors, Aryl Hydrocarbon _xagonists |
650 | 0 | 4 |
_aResorcinols _xadministration & dosage |
650 | 0 | 4 |
_aSkin _xdrug effects |
650 | 0 | 4 |
_aStilbenes _xadministration & dosage |
700 | 1 | _aJayawickreme, Channa | |
700 | 1 | _aRickard, David J | |
700 | 1 | _aNicodeme, Edwige | |
700 | 1 | _aBui, Thi | |
700 | 1 | _aSimmons, Cathy | |
700 | 1 | _aCoquery, Christine M | |
700 | 1 | _aNeil, Jessica | |
700 | 1 | _aPryor, William M | |
700 | 1 | _aMayhew, David | |
700 | 1 | _aRajpal, Deepak K | |
700 | 1 | _aCreech, Katrina | |
700 | 1 | _aFurst, Sylvia | |
700 | 1 | _aLee, James | |
700 | 1 | _aWu, Dalei | |
700 | 1 | _aRastinejad, Fraydoon | |
700 | 1 | _aWillson, Timothy M | |
700 | 1 | _aViviani, Fabrice | |
700 | 1 | _aMorris, David C | |
700 | 1 | _aMoore, John T | |
700 | 1 | _aCote-Sierra, Javier | |
773 | 0 |
_tThe Journal of investigative dermatology _gvol. 137 _gno. 10 _gp. 2110-2119 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jid.2017.05.004 _zAvailable from publisher's website |
999 |
_c27259817 _d27259817 |